BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32927779)

  • 1. Screening oral drugs for their interactions with the intestinal transportome via porcine tissue explants and machine learning.
    Shi Y; Reker D; Byrne JD; Kirtane AR; Hess K; Wang Z; Navamajiti N; Young CC; Fralish Z; Zhang Z; Lopes A; Soares V; Wainer J; von Erlach T; Miao L; Langer R; Traverso G
    Nat Biomed Eng; 2024 Mar; 8(3):278-290. PubMed ID: 38378821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model.
    Masloh S; Chevrel A; Culot M; Perrocheau A; Kalia YN; Frehel S; Gaussin R; Gosselet F; Huet S; Zeisser Labouebe M; Scapozza L
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Options and Techniques to Assess Improved Bioavailability: In Vitro and Ex Vivo Methods.
    Józsa L; Nemes D; Pető Á; Kósa D; Révész R; Bácskay I; Haimhoffer Á; Vasvári G
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery.
    Lu R; Zhou Y; Ma J; Wang Y; Miao X
    Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Porcine Jejunum Ex Vivo to Study Absorption and Biotransformation of Natural Products in Plant Extracts:
    Houriet J; Arnold YE; Pellissier L; Kalia YN; Wolfender JL
    Metabolites; 2021 Aug; 11(8):. PubMed ID: 34436482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?
    Wenzel C; Drozdzik M; Oswald S
    Front Pharmacol; 2021; 12():648388. PubMed ID: 33935750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D organoids derived from the small intestine: An emerging tool for drug transport research.
    Zhang Y; Huang S; Zhong W; Chen W; Yao B; Wang X
    Acta Pharm Sin B; 2021 Jul; 11(7):1697-1707. PubMed ID: 34386316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding
    B Shekhawat P; B Pokharkar V
    Acta Pharm Sin B; 2017 May; 7(3):260-280. PubMed ID: 28540164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early-Stage Drug Development.
    Arnold YE; Kalia YN
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32927779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum.
    Michiba K; Maeda K; Kurimori K; Enomoto T; Shimomura O; Takeuchi T; Nishiyama H; Oda T; Kusuhara H
    Drug Metab Dispos; 2021 Jan; 49(1):84-93. PubMed ID: 33087448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Abundance of Clinically Relevant Drug Transporters in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens.
    Drozdzik M; Busch D; Lapczuk J; Müller J; Ostrowski M; Kurzawski M; Oswald S
    Clin Pharmacol Ther; 2019 May; 105(5):1204-1212. PubMed ID: 30447067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro.
    Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y
    Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
    Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
    Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.